Male Infertility Market Size 2022, Share, Growth & Forecast Till 2027

Male Infertility Market

IMARC Group has recently released a new research study “Male Infertility Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

What are the growth prospects of the Male Infertility Industry?

The global male infertility market size reached US$ 3.55 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.97 Billion by 2027, exhibiting a growth rate (CAGR) of 5.60% during 2022-2027.

Impact of COVID-19:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request For Sample Report

What is a Male Infertility Market?

Male infertility represents a disease of the reproductive system that lowers the chance of the affected individual to impregnate a fertile woman. It can occur, owing to blockages, abnormal sperm function, and low sperm production that prevents the delivery of sperm. Some factors that may contribute to male infertility include genetic defects, undescended testicles, sperm illnesses, injuries, diabetes, or infections, such as chlamydia, gonorrhea, mumps, HIV, etc. It can be treated by vasoepididymostomy, hormone therapy, and assisted reproductive technology (ART) procedures, including in vitro fertilization (IVF) and varicocele surgery. These procedures aid in enhancing the reproductive health of males, restoring testosterone levels, and improving the quality of sperm to enable pregnancy.

What are the major market drivers in the Male Infertility Market ?

The growing incidences of chronic diseases, such as diabetes, obesity, hypertension, etc., on account of sedentary lifestyles and lack of physical activities, are primarily driving the male infertility market. Additionally, the escalating demand for ART procedures, such as IVF, that involve the adoption of previously frozen sperms is further catalyzing the market growth.

Besides this, the rising utilization of deoxyribonucleic acid (DNA) fragmentation techniques and computer-assisted semen analysis to diagnose hypospermia, measure semen volume, and determine male infertility is acting as another significant growth-inducing factor.

Moreover, the easy availability of several infertility treatment drugs, procedures, devices, etc., the increasing workload and the accompanying stress, and unhealthy habits, such as excessive consumption of drugs, alcohol, smoking, etc., are also positively influencing the global market. Apart from this, the launch of various favorable policies by government bodies for improving reimbursement scenarios for infertility-related treatments and enhancing the safety of patient data is propelling the market growth. Furthermore, extensive R&D activities are anticipated to fuel the male infertility market over the forecasted period.

Male Infertility Market Report Scope
Report CoverageDetails
Market size value in 2021US$ 3.55 Billion
Market forecast in 2027 US$ 4.97 Billion
Growth RateCAGR of 5.60% from 2022 to 2027
Base year for estimation2021
Historical data2016-2021
Forecast period2022-2027
Report coverageRevenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends
Segments coveredTest Type, Treatment, Distribution Channel and End User
Regional scopeAsia Pacific, Europe, North America, Latin America, Middle East and Africa
Key companies profiledAndrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.
Market DynamicsParent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization purviewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Breakup by Test Type:

  • Sperm Agglutination
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

Breakup by Treatment:

  • Medication
  • Assisted Reproductive Technology and Varicocele Surgery

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

Breakup by End User:

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Others

By Geography:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

List of Major Key Players:

The major players in the market are  

Andrology Solutions

CinnaGen Co.

Halotech DNA, SCSA Diagnostics Inc.

 Vitrolife, Zydus Lifesciences Limited

Intas Pharmaceuticals Ltd.

and Endo International plc.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming


Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800


Learn More →

Leave a Reply

Your email address will not be published.